Opicapone versus entacapone: Head-to-head retrospective data-based comparison of healthcare resource utilization in people with Parkinson&#39;s new to COMT inhibitor treatment.

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

Comtan (entacapone) - Novartis, Orion Corp

http://www.ncbi.nlm.nih.gov/pubmed/37489574

Francesca Morgante; Glynn Harrison-Jones; Guillermo Castilla-Fernández; K Ray Chaudhuri; Valentina Di Foggia; Xiaocong Li Marston

Jul 25, 2023